In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Papillary Tumor of the Pineal Region: A Patient-level Meta-Analysis on Prognostic Factors for Survival

    Final Number:

    Authors:
    Vitor N Yamaki MD; Davi Jorge Fontoura Solla MD; Renan Ribeiro Ribeiro MD; Saul Almeida da Silva MD; Manoel Jacobsen Teixeira; Eberval G. Figueiredo MD, PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting

    Introduction: Papillary tumor of the pineal region (PTPR) clinical course and biological behavior are still under investigation. The optimal therapeutic approach is yet to be defined. We performed a comprehensive patient-level meta-analysis with all PTPR cases reported thus far to elucidate clinical and treatment features regarding this tumor and identify prognostic factors.

    Methods: A WebOfSciences, Medline and EMBASE search for case series / reports on PTPR (January/2003-June/2017) was performed. Only PTPR cases with individual-level data were included. Data addressing PTPR’s clinical presentation, imaging, treatment and histological features were registered and factors associated with the primary outcome of 36-month survival were identified through Cox regression models.

    Results: Initial search yielded 1054 results, of which 154 remained after screening for relevance. A total 71 studies were included, 60 case reports and 11 case series comprising 175 patients (mean age 33.4±15.4 years, 53.2% male). Headache was the most frequent symptom (82.9%) and 88.6% presented with hydrocephalus. Mean tumor size and volume were 2.9±1.0cm and 8.3±7.1cm³. Surgery was performed on 82.0% and gross total resection (GTR) was achieved on 71.4%. The Glasgow outcome scale was available on 76 cases and its median was 2 (quartiles 1-5). A total 56.8% recurred on a median 28 months (quartiles 11-45). The 36-month survival rate was 83.5%. General mean 36-month survival was 33.6±0.7 months. After multivariate analysis adjusted for age, tumor size (per each additional centimeter, HR 1.99, 95%CI 1.12-3.53, p=0.019) and surgical treatment (HR 0.16, 95%CI 0.06-0.46, p=0.001) were associated with 36-month survival.

    Conclusions: Our results provided information regarding the clinical course and management of PTPR. Tumor size and surgical resection were associated with PTPR survival. We did not find significant benefit on GTR or adjuvant treatment for PTPR, although clinical trials are warranted to overcome the inherent limitations of this study design.

    Patient Care: WE provided concise information about the treatment of a relatively new neoplastic entity which provides improvements in survival rate

    Learning Objectives: By conclusion of this session, we should be able to: 1) Describe the natural history of the papillary tumor of the pineal region; 2) Identify prognostic variables of the PTPR's clinical course; 3) Determine best treatment option for the PTPR's.

    References: 1. Dagnew E, Langford LA, Lang FF, DeMonte F. Papillary tumors of the pineal region: Case report. Neurosurgery. 2007;60(5) 2. Fauchon F, Hasselblatt M, Jouvet A, et al. Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: A multicenter study. J Neurooncol. 2013;112(2):223-231

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy